Expressions for a healthy life

Our Products

Discover Intas B2B extensive pipeline and dossier portfolio differentiated in three main areas: Generics, Biosimilars and Added Value Medicines (AVM).

More than 140 dossiers approved in different jurisdictions
Intas biologics business unit develops and manufactures high-quality biosimilars that are commercialized across all continents
Added Value Medicines
Intas AVM business unit is constantly looking for innovative formulas

Intas B2B around the world

Intas B2B is composed by a fully-fledge support global team of 45 people (from our Global offices in Barcelona and, also spread around the globe) to cover the demand of our customers.

Key Facts

+ 1


+ 1


+ 1


1 %
1 %


Latest News

Christmas Toys Campaign
Casal dels Infants collaborationTogether, let´s give a Child a Christmas!
Our NEW e-Portfolio is here!
Get it now! Discover the new design and experience all our new features!
Thank you for visiting
Thank you Team & Partners. See you next year in Barcelona.

Contact us

If you want more information or advice about our services, contact us and we will respond shortly.